The world’s first device for endotracheal intubation that protects clinicians while facilitating the procedure.
Effective barrier for aerosols and droplets, reduces infection risk.
Disruptive concept, smart design, revolutionary technology.
Endotracheal Intubation: An Aerosol Generating Procedure
ETI is a complex and high-risk procedure only performed by highly trained clinicians. More than 50 million intubations are performed worldwide per year. It is the third most common procedure in US hospitals. The global airway management market value is 1.6 billion € per year.
ETI permits mechanical ventilation in patients with severe respiratory failure, in the context of COVID-19 or other causes. It is also required in most surgeries.
It is an aerosol generating procedure (AGP) with high risk of infection for the operators. At present, clinicians represent 5.46 % of total COVID-19 cases in Spain, with a total of more than 79,000 cases.
The current COVID-19 pandemic has compelled the medical community worldwide to search for a device that could make ETI safer, both for patients and for clinicians. In this context, the Airway ShieldTM is a groundbreaking solution: a unique, disposable device that makes intubation safer for both patient and clinical staff, is easy to operate with minimal training, and is highly cost-effective.
The Airway ShieldTM
An innovative low-cost and safe solution for minimizing risks of ETI procedure.
The COVID-19 pandemic has raised an urgent need for adequate protective measures during high-risk aerosol-generating procedures such as endotracheal intubation (ETI).
Current clinical guidelines for airway management encourage clinicians to focus on using appropriate contact and airborne precautions.
The Airway ShieldTM is a cost-effective and revolutionary barrier device that protects medical staff during intubation procedures.
How it works
The simple yet innovative operating mechanism behind the Airway ShieldTM consists in supporting the tongue while creating a channel for the endotracheal tube (ETT), so it can easily follow the direction set by the laryngoscope blade towards the larynx.
Placing the Airway ShieldTM
Carefully following the palate, the device is introduced into the mouth until the shield is covering the mouth of the patient. The shield protects the operators from droplets and aerosols.
Like in a standard intubation, the video-laryngoscope is introduced first to obtain the view of the larynx, and then the ETT is introduced. The channel of the device facilitates the introduction of the ETT following the blade of the laryngoscope towards the larynx.
Removing the Airway ShieldTM
Once the ETT is in place and the ventilator is connected, the Airway ShieldTM is peeled away from the midline and removed. The exposure to aerosols and droplets has been minimized.
The Airway ShieldTM is a cost-effective, safe, and innovative solution for avoiding clinician exposure to aerosols and droplets during airway management.
Facilitates intubation, making the procedure safer.
Protects clinicians from the risk of infection.
Reduce Aerosols and Droplets
Reduces exposure for all involved in the procedure.
Easy to use
Minimal training required.
Available and ready to use in any circumstance.
Simple solution to a complex problem.
Revolutionary yet simple design.
Design and method protected by an international patent.
What the experts have to say about our device
“Simple, intuitive and easy to use. This device facilitates intubation and provides safety to the professional against the generation of aerosols.”Ana MendigurenAnaesthesiologist, University Hospital Araba
“A barrier that can be crucial in the professional protection.”Mikel BibankoAnaesthesiologist, University Hospital Araba
“A breakthrough in the field of security combined with easy to use technology, even for those with little experience.”Jon RenteriaSecond-Year Resident in Anaesthesiology, University Hospital Araba
“Device easy to use, comfortable to place and facilitates ventilation and intubation, using laryngoscope as well as videolaryngoscope. And at the same time protects you against aerosols.”Fidel de CelisAnaesthesiologist, University Hospital Araba
Our product roadmap with milestones from the conceptualization phase in April-May 2020 to our commercial launch in July-August 2021.
First 3D Printing Prototypes
International Patent Filed (PCT)
Preclinical Studies Completed
Initial Contacts with Manufacturers
Initial Distributors Selection
First Injection Molding Tool Contracted
First Clinical Study Design / Scientific Outreach Program Development
Preclinical Studies Under Review
Pre-Production Samples for Testing
Private Funding Round
Preclinical Studies Approved for Publication
Launch of Crowdfunding Campaign
Get in touch
Calle Moctezuma 3, 1B Santander.
39003 Cantabria. Spain
+34 621 317 148